Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia

被引:18
|
作者
Procianoy, Renato S. [1 ,2 ]
Hentges, Claudia R. [1 ,2 ]
Silveira, Rita C. [1 ,2 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Newborn Sect, Porto Alegre, RS, Brazil
关键词
preterm neonates; VEGF/PIGF heterodimer; angiogenesis; respiratory distress syndrome; bronchopulmonary dysplasia; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; ANGIOGENESIS; VEGF; ASTHMA; PREECLAMPSIA; RECEPTOR-1; EXPRESSION; DISCOVERY;
D O I
10.1055/s-0035-1566294
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Bronchopulmonary dysplasia (BPD) is associated with changes in pulmonary angiogenesis. However, the role of the vascular endothelial growth factor/placental growth factor (VEGF/PIGF) heterodimer, an antiangiogenic factor, remains unknown in this disease. Objective To compare VEGF/PIGF levels in preterm infants with and without BPD. Methods This study was approved by the Institutional Review Board. Preterm neonates with birth weight <2,000 g and gestational age <= 34 weeks were included. Exclusion criteria were: neonates transferred from other institutions after 72 hours of life; death before blood collection; presence of major congenital malformations, inborn errors of metabolism, and early sepsis; and mothers with multiple pregnancies, TORCH infections, HIV infection, or autoimmune diseases. BPD was defined as the need for oxygen therapy for a period equal to or greater than 28 days, accompanied by radiographic changes compatible with the disease. Blood was collected from neonates in the first 72 hours of life. VEGF/PIGF levels were measured using the enzyme-linked immunosorbent assay method. The chi-square test, t-test, Mann Whitney test, analysis of variance, and Kruskal Wallis test were used for statistical analysis. Variables found to be significant in the univariate analysis were included in the multivariate analysis. Results Seventy-three patients were included (19 with BPD, 43 without BPD, and 11 neonates who died in the first 28 days of life), with a mean (SD) gestational age of 30.32 (2.88) weeks and birth weight of 1,288 (462) g. Median VEGF/PIGF levels were higher in the groups with BPD and death in the first 28 days of life than in the group without BPD (16.46 [IQR, 12.19-44.57] and 20.64 [IQR, 13.39-50.22], respectively, vs. 9.14 [IQR, 0.02-20.64] pg/mL], p < 0.001). Higher VEGF/P1GF levels remained associated with BPD and death in the first 28 days of life in the multivariate analysis. Conclusion Higher plasma VEGF/PIGF levels were found in preterm neonates with BPD and in those who died in the first 28 days of life, suggesting an important role of this substance in pulmonary vascular development.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 50 条
  • [11] Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity
    Peirovifar, Ali
    Gharehbaghi, Manizheh Mostafa
    Gharabaghi, Parvin Mostafa
    Sadeghi, Karim
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (12) : 709 - 712
  • [12] Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro
    Crocker, IP
    Strachan, BK
    Lash, GE
    Cooper, S
    Warren, AY
    Baker, PN
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2001, 8 (06) : 341 - 346
  • [13] Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis
    Young, H. S.
    Kamaly-Asl, I. D.
    Laws, P. M.
    Pemberton, P.
    Griffiths, C. E. M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (03) : 302 - 308
  • [14] Vascular Endothelial Growth Factor But Not Placental Growth Factor Promotes Trophoblast Syncytialization In Vitro
    Ian P. Crocker
    Bryony K. Strachan
    Gendie E. Lash
    Suzanne Cooper
    Averil Y. Warren
    Philip N. Baker
    The Journal of the Society for Gynecologic Investigation: JSGI, 2001, 8 (6): : 341 - 346
  • [15] Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia
    Livingston, JC
    Chin, R
    Haddad, B
    Mckinney, ET
    Ahokas, R
    Sibai, BM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (06) : 1554 - 1557
  • [16] Role of vascular endothelial growth factor and placental growth factor in chronic airway inflammation
    Bobic, S.
    De Vooght, G.
    Callebaut, I
    Hox, V
    Ceuppens, J.
    Hellings, P.
    ALLERGY, 2009, 64 : 510 - 511
  • [17] Serum Placental Growth Factor, Vascular Endothelial Growth Factor, Soluble Vascular Endothelial Growth Factor Receptor-1 and -2 Levels in Periodontal Disease, and Adverse Pregnancy Outcomes
    Sert, Tuba
    Kirzioglu, F. Yesim
    Fentoglu, Ozlem
    Aylak, Firdevs
    Mungan, Tamer
    JOURNAL OF PERIODONTOLOGY, 2011, 82 (12) : 1735 - 1748
  • [18] Growth and body composition in preterm infants with bronchopulmonary dysplasia
    Huysman, WA
    de Ridder, M
    de Bruin, NC
    van Helmond, G
    Terpstra, N
    Van Goudoever, JB
    Sauer, PJJ
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2003, 88 (01): : 46 - 51
  • [19] Anti-Vascular Endothelial Growth Factor Antagonists: A Potential Primary Prevention for Bronchopulmonary Dysplasia?
    McEvoy, Cindy T.
    Durand, Manuel
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) : 703 - 704
  • [20] Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns
    Kazumichi Fujioka
    Akio Shibata
    Tomoyuki Yokota
    Tsubasa Koda
    Miwako Nagasaka
    Mariko Yagi
    Yasuhiro Takeshima
    Hideto Yamada
    Kazumoto Iijima
    Ichiro Morioka
    Scientific Reports, 4